Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 2
This study was to see if a chemotherapy drug called azacitidine helped to stop acute myeloid leukaemia (AML) coming back after a stem cell transplant. The people in this trial had reduced doses of chemotherapy before their transplant (a reduced intensity transplant).
Recruitment start: 1 April 2009
Recruitment end: 5 July 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Charles Craddock
Cancer Research UK Clinical Trials Unit, University of Birmingham
Bloodwise
Celgene Ltd
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 1 December 2015
CRUK internal database number: 4054
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
